论文部分内容阅读
人们普遍认为,在发展中国家推行全国性的乙型肝炎疫苗免疫接种计划是合乎需要的。但至今为止,由于疫苗的昂贵价格,使这一计划受到限制。为确定乙型肝炎疫苗可能的最低价格,在一个5000万人口的发展中国家中进行疫苗生产的研究。这项研究的结论:在一些发展中国家生产血清乙型肝炎疫苗可能是合理的。一项详细的财政费用评价分析得出几个结论。在一个假设5000万人口的国家中,如果每年生产400万支血清乙型肝炎疫苗,那么售价为每支0.50美元,每盒包装10支。要建设这些药厂,一开始必须投
It is generally accepted that a national hepatitis B vaccine immunization program is desirable in developing countries. So far, however, this plan has been limited by the high cost of vaccines. To determine the lowest possible price for a Hepatitis B vaccine, a vaccine production study was conducted in a developing country of 50 million people. Conclusions from this study: It may be reasonable to produce a serum hepatitis B vaccine in some developing countries. A detailed analysis of financial expense analysis draws a few conclusions. In a hypothetical country of 50 million people, if 4 million Hepatitis B vaccines are to be produced each year, the price is $ 0.50 per pack and 10 per pack. To build these pharmaceuticals, the beginning must vote